Ultrabright nanoparticle-labeled lateral flow immunoassay for detection of anti-SARS-CoV-2 neutralizing antibodies in human serum

The level of anti-SARS-CoV-2 neutralizing antibodies (NAb) is an indispensable reference for evaluating the acquired protective immunity against SARS-CoV-2. Here, we established an ultrabright nanoparticles-based lateral flow immunoassay (LFIA) for one-step rapid semi-quantitative detection of anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Lun, Li, Zhaoyue, He, An, Wu, Biru, Yang, Hui, Wu, Yingsong, Hu, Fang, Lin, Guanfeng, Zhang, Deqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360774/
https://www.ncbi.nlm.nih.gov/pubmed/35977850
http://dx.doi.org/10.1016/j.biomaterials.2022.121694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360774/
https://www.ncbi.nlm.nih.gov/pubmed/35977850
http://dx.doi.org/10.1016/j.biomaterials.2022.121694

Ejemplares similares